Status:

UNKNOWN

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

Lead Sponsor:

Gabriela Riemekasten

Collaborating Sponsors:

European Union

University of Giessen

Conditions:

Systemic Sclerosis

Interstitial Lung Diseases

Eligibility:

All Genders

Brief Summary

Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the connective tissue of the skin and all internal organs. Interstitial lung disease is a frequent morbidity and mortality-driving m...

Detailed Description

Patients are routinely evaluated every 3 months over a 12-months period by medical history, physical examination, pulmonary function tests, VAS lung score and SF-36, SHAQ. Also, their medication and p...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis fo SSc according to the ACR/EULAR criteria for adult or the PRES/ACR/EULAR criteria for juvenile SSc patients
  • SSc patients with proven ILD (by X-ray or CT scan)
  • Treatment with standard dosages according to current practice with (i) cyclophosphamide, (ii) azathioprine, (iii) mycophenolate mofetil, (iv) methotrexate, or (v) no therapy
  • Exclusion Criterion:
  • Patients with previous exposure to silica or asbestos

Exclusion

    Key Trial Info

    Start Date :

    May 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 1 2016

    Estimated Enrollment :

    1372 Patients enrolled

    Trial Details

    Trial ID

    NCT01858259

    Start Date

    May 1 2013

    End Date

    June 1 2016

    Last Update

    August 13 2014

    Active Locations (11)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (11 locations)

    1

    Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A & INSERM 1016

    Paris, France, 75014

    2

    Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology

    Bad Nauheim, Germany, 61231

    3

    Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

    Berlin, Germany, 10117

    4

    Centre for Pediatric Rheumatology, Klinikum Eilbek

    Hamburg, Germany, 22081